David-Alexandre C Gros
CIK 1644489 · View on SEC EDGAR ↗
First SEC filing: Sept. 15, 2020 · Latest: Sept. 15, 2020
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 20, 2021 | ELDN | P | 2,000 | $4.48 | $8,960 | 9,000 Direct | +28.57% | Acquired | -21.2% (price as of 2026-08-20) |
| Aug. 17, 2021 | ELDN | P | 4,000 | $6.21 | $24,840 | 7,000 Direct | +133.33% | Acquired | -43.2% (price as of 2026-08-20) |
| June 9, 2021 | ELDN | P | 3,000 | $8.01 | $24,030 | 3,000 Direct | — | Acquired | -55.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 10, 2025 | ELDN | Restricted Stock Units | Common Stock (66,500) | — | — | 66,500 | Acquired |
| Jan. 10, 2025 | ELDN | Stock Option (right to buy) | Common Stock (600,000) | $4.04 | Jan. 10, 2035 | 600,000 | Acquired |
| Nov. 21, 2024 | ELDN | Stock Option (right to buy) | Common Stock (1,015,743) | $2.30 | May 1, 2033 | 1,015,743 | Acquired |
| June 13, 2024 | ELDN | Stock Option (right to buy) | Common Stock (517,454) | $2.30 | May 1, 2033 | 517,454 | Acquired |
| May 1, 2023 | ELDN | Common Stock (right to buy) | Common Stock (383,299) | $2.30 | May 1, 2033 | 383,299 | Acquired |
| Feb. 1, 2023 | ELDN | Stock Option (right to buy) | Common Stock (153,600) | $3.97 | Feb. 1, 2032 | 153,600 | Acquired |
| Feb. 1, 2023 | ELDN | Stock Option (right to buy) | Common Stock (300,000) | $3.08 | Feb. 1, 2033 | 300,000 | Acquired |
| Feb. 1, 2022 | ELDN | Stock Option (right to buy) | Common Stock (108,000) | $3.97 | Feb. 1, 2032 | 108,000 | Acquired |
| Sept. 11, 2020 | ELDN | Stock Option (Right to Buy) | Series X1 Convertible Preferred Stock [F2] (18,278) | $500.00 | Sept. 11, 2020 | 18,278 | Acquired |
| Feb. 6, 2017 | NBIX | Restricted Stock Option | Common Stock (25,000) | — | — | 25,000 | Acquired |
| Feb. 1, 2017 | NBIX | Stock Option | Common Stock (350,000) | $42.55 | Feb. 1, 2027 | 350,000 | Acquired |
| Dec. 20, 2016 | ALNY | Stock Option (right to buy) | Common Stock (25,000) | $42.22 | Dec. 20, 2026 | 25,000 | Acquired |
| Dec. 18, 2015 | ALNY | Stock Option (right to buy) | Common Stock (15,012) | $88.95 | Dec. 18, 2025 | 15,012 | Acquired |
| June 8, 2015 | ALNY | Stock Option (right to buy) | Common Stock (140,000) | $129.97 | June 8, 2025 | 140,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $513,221 | — | — | — | — | — | — | $11,357,203 |
ALNY
PFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $8,313 | — | — | — | — | — | $8,541 | $16,854 |
| 2016 | $432,300 | $100,000 | — | — | $138,336 | — | $1,610 | $1,293,204 |
| 2015 | $241,106 | $200,000 | — | — | $95,819 | — | $508 | $10,168,230 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $613,196 | — | $268,660 | — | $349,522 | — | $21,690 | $3,216,148 |
| 2024 | $582,269 | — | — | — | $464,277 | — | $21,390 | $5,644,970 |
| 2023 | $559,478 | — | — | — | $286,383 | — | $20,490 | $2,553,153 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.